There is limited knowledge about hormonal control of progesterone-induced CK5-positive cells in breast cancer. Despite extensive interactions between progesterone and prolactin in the control of ...
Protein cytokeratin 5 (CK5), known to be a marker of poor prognosis in breast cancer, also marks ovarian cancers likely to be resistant to the common chemotherapy cisplatin, new research confirms. A ...
November 3, 2009 (Chicago, Illinois) — In breast biopsies, the absence of cytokeratin 5 (CK5) expression in atypical ductal hyperplasia (ADH) cells is highly predictive of the likelihood that the ...
A University of Colorado Cancer Center study recently published in the International Journal of Gynecological Cancer shows that protein cytokeratin 5 (CK5), known to be a marker of poor prognosis in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results